Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
COVID-19
SARS-COV-2
Switzerland
coronavirus disease
cross-infection
infection control
infectious disease transmission
nosocomial infections
risk factors
severe acute respiratory syndrome coronavirus 2
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
pubmed:
2
9
2022
medline:
24
9
2022
entrez:
1
9
2022
Statut:
ppublish
Résumé
Of 1,118 patients with COVID-19 at a university hospital in Switzerland during October 2020-June 2021, we found 83 (7.4%) had probable or definite healthcare-associated COVID-19. After in-hospital exposure, we estimated secondary attack rate at 23.3%. Transmission was associated with longer contact times and with lower cycle threshold values among index patients.
Identifiants
pubmed: 36048771
doi: 10.3201/eid2810.220321
pmc: PMC9514341
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2087-2090Références
Vaccine. 2022 Jan 31;40(5):701-705
pubmed: 34953607
Lancet. 2021 May 1;397(10285):1603-1605
pubmed: 33865497
Clin Infect Dis. 2022 Mar 23;74(6):1097-1100
pubmed: 34145449
Am J Infect Control. 2021 Dec;49(12):1464-1468
pubmed: 34551334
J Hosp Infect. 2020 Nov;106(3):621-625
pubmed: 32841703
Emerg Infect Dis. 2022 Oct;28(10):2134-2137
pubmed: 36001791
Infect Control Hosp Epidemiol. 2021 Jul 12;:1-4
pubmed: 34250882
Clin Infect Dis. 2022 May 3;74(9):1579-1585
pubmed: 34329418
Clin Infect Dis. 2021 Feb 16;72(4):690-693
pubmed: 32562422
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S138-S145
pubmed: 33045075
Emerg Microbes Infect. 2022 Dec;11(1):1-5
pubmed: 34890524
J Visc Surg. 2020 Jun;157(3S1):S13-S18
pubmed: 32381426
Emerg Microbes Infect. 2022 Dec;11(1):337-343
pubmed: 34935594